These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723 [TBL] [Abstract][Full Text] [Related]
5. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. Fiesel FC; Kahle PJ FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389 [TBL] [Abstract][Full Text] [Related]
6. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? Baloh RH Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957 [TBL] [Abstract][Full Text] [Related]
7. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases. Wang XN; Cui LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664 [TBL] [Abstract][Full Text] [Related]
9. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. Bentmann E; Haass C; Dormann D FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD). Lourenco GF; Janitz M; Huang Y; Halliday GM Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395 [TBL] [Abstract][Full Text] [Related]
11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125 [TBL] [Abstract][Full Text] [Related]
12. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367 [TBL] [Abstract][Full Text] [Related]
13. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033 [No Abstract] [Full Text] [Related]